Trial to Evaluate Efficacy and Safety of Pembrolizumab and Gemcitabine in HER2-negative ABC

NCT03025880 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Advanced Breast Cancer

Interventions

DRUG: Pembrolizumab
DRUG: Gemcitabine

Sponsor

Spanish Breast Cancer Research Group

Collaborators

[object Object]